Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Halozyme Therapeutics (NASDAQ:HALO) through any online brokerage.
Other companies in Halozyme Therapeutics’s space includes: Immunovant Inc (NASDAQ:IMVT), Avidity Biosciences Inc (NASDAQ:RNA), Cogent Biosciences Inc (NASDAQ:COGT), PTC Therapeutics Inc (NASDAQ:PTCT) and Vaxcyte Inc (NASDAQ:PCVX).
Halozyme Therapeutics has a consensus price target of $69.29.
The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $63.545 last updated December 16, 2025 at 10:29 AM EST.
There are no upcoming dividends for Halozyme Therapeutics.
Halozyme Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Halozyme Therapeutics.
Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.